Riskpilot← Back to searchSign inGet full accessPHARMA NORDIC AS
ASActiveOrg 9290649095 Etg Storgata 38, 6002 ÅlesundWholesale of pharmaceutical and medical goods · NACE 4646Est. 20227 employees
Revenue 2024
NOK 4,1M
+2501% vs 2023
EBITDA margin
-428.8%
-133% vs 2023
Equity ratio
84.1%
Financial strength
Net profit 2024
NOK -14,1M
-136% vs 2023
| Revenue | NOK 4,1M | +2501% |
| EBITDA | NOK -17,6M | -133% |
| Net profit | NOK -14,1M | -136% |
| Total assets | NOK 23,8M | +385% |
| Equity | NOK 20M | +2718% |
| Employees | 7 | — |
Legal name
PHARMA NORDIC AS
Org number
929064909
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. april 2022
Share capital
NOK 253 565
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Lisensiering - salg, markedsføring, forskning og utvikling av naturbaserte legemidler, medisinsk teknisk utstyr, legemidler og annet helserelaterte produkter, samt det som naturlig står i forbindelse med dette.
Address
5 Etg Storgata 38, 6002 Ålesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 85 | 158 | 4 113 |
| Staff expenses | −0 | −1 190 | −2 853 |
| EBITDA | −2 524 | −7 556 | −17 639 |
| Depreciation & amort. | −0 | −0 | −47 |
| EBIT | −2 524 | −7 556 | −17 686 |
| Net financials | −13 | −69 | −364 |
| Profit before tax | −2 536 | −7 625 | −18 049 |
| Tax | −551 | −1 639 | −3 937 |
| Net profit | −1 986 | −5 986 | −14 112 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 2 487 | 4 905 | 23 770 |
| Equity | 71 | 710 | 19 998 |
| Long-term debt | 0 | 0 | 1 658 |
| Short-term debt | 2 416 | 4 196 | 2 115 |
| Total debt | 2 416 | 4 196 | 3 773 |
EBITDA margin
-428.8%
This company
15.8%
Market median
-2814% vs market
20222024
Equity ratio
84.1%
This company
38.2%
Market median
+120% vs market
20222024
Return on equity
-70.6%
This company
18.4%
Market median
-484% vs market
20222024
Net profit margin
-343.1%
This company
8.1%
Market median
-4336% vs market
20222024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20222024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20222024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-02-24 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BL Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 15.9% | 15.9% | 2024 | |
Ba&Sa Holding As | Company | 13.3% | 13.3% | 2024 |
| Individual | 12.7% | 12.7% | 2024 | |
Simplyfish As | Company | 12.1% | 12.1% | 2024 |
Erm Invest As | Company | 8.1% | 8.1% | 2024 |
Legeregnskap Eiendom As | Company | 7.0% | 7.0% | 2024 |
Kaper Pharma Ag | Company | 3.9% | 3.9% | 2023 |
W. Zurhaar Holding As | Company | 3.0% | 3.0% | 2024 |
John Knudsen Holding As | Company | 3.0% | 3.0% | 2024 |
Stamsaas Holding As | Company | 1.8% | 1.8% | 2024 |
Svein Gressløs Invest As | Company | 1.7% | 1.7% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PHARMA NORDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bent Lorang Andreassen | Chief Executive Officer | 0 companies |
| Helge Ivar Strømskag | Chairman | 0 companies |
| Hans Tomter | Board of Directors | 0 companies |
| Geir Riise | Board of Directors | 0 companies |
| Kjetil Høye | Board of Directors | 0 companies |
| Ulf Rune Visur Syversen | Chairman | 0 companies |
| Synnøve Longva Andreassen | Board of Directors | 0 companies |
| Heidi Kristin Bjørnslett Haugen | Board of Directors | 0 companies |
| Siv Jensen | Board of Directors | 0 companies |
| Wolfgang Maria Koppe | Board of Directors | 0 companies |